Cannabis Law Report

JUNE 4, 2021

– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. The poster presentation of the data was by Dr. Scott Tagawa , a Professor of Medicine & Urology at Weill Cornell Medicine and an AIkido Pharma Scientific Advisory Board member. – Phase 2 Trial Underway. AIkido Pharma Inc.:

Data 100

Data Research and Development Clinical Trials Therapy 100

Veriheal

MAY 30, 2023

In this article, we’ll delve into the newest research findings and explore how medicinal cannabis could revolutionize cancer pain management and reduce reliance on opioids and other medications. of the patients reported pain as their primary motivation for obtaining a medicinal cannabis prescription. Interestingly, 72.5%

Medicine 98

Medicine Treatment Patients Data 98

Medicinal Genomics

JULY 14, 2022

The truth is that total count tests are not a good indicator of cannabis and hemp product safety for the following reasons: Pathogenic microbes may still be present Testing methods often do not agree Growers are discouraged from using beneficial microbes Growers are encouraged to use remediation. fumigatus, A.

Safety 92

Safety Research and Development Concentrates Food 92

Cannabis Law Report

AUGUST 5, 2019

The two-year experiment is being overseen by the French Agency for Drug Safety (ANSM), which drew up a 13-name committee to explore the possibilities of reform in one of Europe’s largest markets in December 2018. France is searching for patients to take part in an official medical cannabis trial, but users will not be smoking the drug.

Medicine 60

Medicine Patients Digestion Epilepsy 60

Cannabis Law Report

JULY 13, 2021

As the psychedelic renaissance contributes to a swelling pool of safety and efficacy data pertaining to the potential therapeutic benefits of psychedelic medicine, many localities—particularly in North America—are revising their legal frameworks. This is what they are saying. Mapping Psychedelic Drug Policy Reform.

Decriminalization 105

Decriminalization Legalization Data Safety 105

Cannabis Law Report

MAY 18, 2022

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Their participation strengthened the statistical reliability of both the liver safety results and achieved statistical relevance for both sleep and testosterone results.

Safety 52

Safety Hemp Research and Development Data 52

Cannabis Law Report

MAY 18, 2022

NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE , AMPLIFIES CALLS FOR FDA REGULATION. Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. The second cohort included an additional 222 individuals taking CBD produced by an additional five companies.

Safety 52

Safety Hemp Research and Development Data 52

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

NORML

AUGUST 26, 2019

HB1445/SB1235, unfortunately, didn’t provide a framework for cultivating or distributing medicines, so patients had to get their cannabis from another state (a no-no under the US Department of Justice’s now-rescinded guidelines ). The certificate provides an affirmative defense for possession of those medicines.

Marijuana 248

Marijuana Legalization Programs Oil 248

Veriheal

AUGUST 24, 2023

Christopher Simpson, a deputy director at the Pacific Northwest Agricultural Safety and Health Center, believes that overall, the risk of DDE in cannabis is likely low. “To There just isn’t experimental data available,” Simpson said. There just isn’t experimental data available,” Simpson said.

Data 98

Data Safety Extraction Cannabis 98

Cannabis Law Report

AUGUST 27, 2021

The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future. Chris Ray , PhD : Interventional Pain Physician.

Research and Development 98

Research and Development Treatment Media Medicine 98

Cannabis Law Report

DECEMBER 16, 2019

There’s a another medicinal cannabis company with its sights on the ASX boards. Emerald Clinics captures clinical data from patients to generate evidence for the safety and efficacy of cannabis medicines. Marta Pascual Juanola.

Medicine 45

Medicine Data Safety Therapy 45

The Cannigma

FEBRUARY 2, 2021

As medicinal cannabis treatments are now legal in many parts of the world, naturally, there is a growing interest in whether the products can treat neurological conditions like Parkinson’s disease. Physicians should consider these aspects when advising their patients about treatment with medicinal cannabis.

Patients 98

Patients Clinical Trials Research and Development Treatment 98

LifeCannMD

MAY 27, 2025

#image_title By Dr. Fernando Fandio-Sende, LifeCannMD After thirty years practicing medicine and specializing as a Miami cannabis doctor , I’ve had countless conversations with patients who tell me the same thing: “Doctor, I want to try medical marijuana , but I’m scared of getting too high.” hours longer per night.

Microdosing 52

Microdosing Research and Development Sleep Chronic Pain 52

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients. About RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

JANUARY 27, 2020

We take a look at where CBD regulation might be going and whether we should be concerned about safety writes Rob Verkerk PhD, scientific and executive director, ANH-Intl. We take a look at where CBD regulation might be going and whether we should be concerned about safety. A new ‘problem’: safety. ? A new ‘problem’: safety.

Safety 59

Safety CBD Food Seed-To-Sale 59

Cannabis Law Report

NOVEMBER 2, 2021

This updated edition reviews over 450 peer-reviewed studies assessing the safety and efficacy of either whole-plant cannabis or individual cannabinoids in 23 different patient populations, including autism , chronic pain , diabetes , fibromyalgia , migraine , and post-traumatic stress.

Safety 52

Safety Patients Chronic Pain Advocacy 52

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. The use of cannabis as a therapeutic and medicinal aid is widely supported.

Consumption 111

Consumption Patients Research and Development Data 111

NORML

FEBRUARY 26, 2019

In addition to fighting to defend the privacy of medical marijuana patients, advocates are also educating lawmakers about the discriminatory nature of drug testing and the benefits of impairment detection to address workplace safety. You can’t tell them about Maddie’s medicine. Cannabis is illegal.

Legislation 216

Legislation Education Law Programs 216

Cannabis Law Report

APRIL 1, 2022

Aguilar has suggested that “cannabis must have similar authorization and use conditions” to those that operate in Spain with products such as morphine and has opened the door for, at one time, community pharmacies -and not just hospital ones- dispense cannabinoid-based products that the Medicines Agency may authorize.

Medicine 52

Medicine Data Safety Conditions 52

Cannabis Law Report

AUGUST 10, 2021

–(BUSINESS WIRE)– PSI Labs , an Ann Arbor, Michigan-based ISO 17025 accredited Safety Compliance Facility that provides essential cannabis testing services, today announced its expansion into Southern California with the acquisition of pH Solutions, LLC. Monrovia-Based Lab Acquisition Strengthens Cannabis Testing In California.

Research and Development 81

Research and Development Compliance Compliance Safety 81

Veriheal

JUNE 24, 2022

While it’s true that cannabis impacts various driving-related skills , a recent study published in Preventative Medicine Reports found that states with legal cannabis actually had fewer impaired driving incidents. Still, the results of the study are statistically significant, and further research will provide more data on the subject.

Legalization 98

Legalization Education Recreational Data 98

Veriheal

MAY 19, 2023

The review period will give employers a chance to identify safety-sensitive positions for which the new drug test ban is not appropriate. SB 5132 already has a number of exceptions built-in for safety-sensitive jobs like law enforcement, firefighting, and first responders. So, how exactly is ketamine able to do this?

Chronic Pain 97

Chronic Pain Data Consumption Safety 97

Veriheal

MAY 16, 2022

Researchers working at the University of Arizona College of Medicine in Tucson have refined a method of ketamine use in the treatment of Parkinson’s disease (PD). Once known solely as a party drug, ketamine is starting to earn a new reputation thanks to research efforts into its potentially medicinal qualities.

Research and Development 19

Research and Development Treatment Clinical Trials Patients 19

Cannabis Law Report

DECEMBER 2, 2021

Generally, medicinal cannabis products are only available, on prescription, if they have: been assessed by the Medicinal Cannabis Agency as meeting the minimum quality standard under the Misuse of Drugs (Medicinal Cannabis) Regulations 2019, or. Prescription Medicine. Prescription Medicine. Prescription Medicine.

Medicine 52

Medicine Pharmaceutical Sativa THC 52

Cannabis Law Report

DECEMBER 19, 2021

17 December 2021: New medicinal cannabis products have been verified as meeting the minimum quality standard – Read more. obtained consent for distribution under the Medicines Act 1981 (approved and provisionally approved medicines). Prescription medicine. Prescription Medicine. Prescription Medicine.

Medicine 52

Medicine Pharmaceutical THC Sativa 52

Veriheal

MARCH 14, 2022

Cannabis and driving could be a recipe for disaster, say researchers from the Center for Medicinal Cannabis Research in the University of California San Diego. . In order to come to their conclusion, the team analyzed reported data from more than 191 regular hashish consumers. Although performance was improving at 3.5

Research and Development 98

Research and Development Consumption THC Concentrates 98

Cannabis Cheri

NOVEMBER 27, 2018

Besides being commonly used in perfumes and incense, Frankincense has many medicinal uses in common with cannabis including reducing pain, inflammation, anxiety, and stress. We currently have little data and science to go on as to optimal topical dosages. Like edibles, dosing for topicals is highly individualized.

Topical 188

Topical Oil Marijuana THC 188

Veriheal

APRIL 11, 2022

The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website. This means that U.S.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

Cannabis Law Report

NOVEMBER 24, 2019

Building the bridge between brands and the marketplace through testing and the importance of good data. These events, amongst other drivers, have shown the obvious need to regulate product safety in CBD and THC products in a holistic and standardized way.

Business 95

Business Data Wellness and Beauty Safety 95

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Peer-reviewed analysis.

Cannabinoids 45

Cannabinoids Data Chronic Pain Sleep 45

The Joint Blog

JULY 14, 2021

Medicinal CBD is helping seniors improve their quality of life. The low THC content ensures that you can reap all its medicinal benefits without having to get high. There has been inadequate research conducted and not enough data that fully supports the use of CBD for the elderly. Some adults over the age of 65 are using CBD.

Medicine 52

Medicine CBD Chronic Pain Oil 52

Cannabis Law Report

SEPTEMBER 15, 2021

Thus, historical use of cannabis cannot be relied upon in establishing a level of safety for these products in humans. The FDA will warn consumers about public health and safety issues and take action, when necessary, when FDA-regulated products violate the law. For more information about Delta-8 THC: CDC HEALTH ALERT NETWORK (HAN).

THC 105

THC Pets Events Hemp 105

Cannabis Law Report

JULY 30, 2019

Cannabis-based products will be allowed to bypass usual processes required for medicines in New Zealand and go directly onto the market without any proof of safety or effectiveness. This unprecedented proposal is contained in the government’s consultation document on giving greater access to medicinal cannabis.

Medicine 40

Medicine Clinical Trials Safety Access 40

The Cannigma

AUGUST 31, 2021

The poll was carried out by People Science , a tech-enabled science company that describes its mission as bringing together “health minded people, research scientists, and healthcare providers in an effort to unlock the potential of alternative medicines.”.

Education 105

Education Clinical Trials Medicine Policy 105

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.

Research and Development 122

Research and Development Data THC Clinical Trials 122